Wednesday, 19 June 2019

DSM launches cGMP facility in Brisbane

31 October 2013 | News | By BioSpectrum Bureau

DSM Pharma launches new cGMP facility for biopharmaceutical contract manufacturing in Australia

DSM Pharma launches new cGMP facility for biopharmaceutical contract manufacturing in Australia

Singapore: DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has launched its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia.

The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia.

The Brisbane facility offers cGMP mammalian cell culture contract manufacturing services from process development through to commercial manufacturing.

Mr Lukas Utiger, president and CEO, DSM Pharmaceutical Products, stated that, "With its flexible design and use of single-use technology, the facility represents the model for the future of biomanufacturing. It represents an important milestone in the development of Australia-based mammalian cell-based manufacturing of biopharmaceuticals, and extends DSM's contribution to the global biotechnology market."

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls